Previous 10 | Next 10 |
PacBio Unveils a New Method for Comprehensive, Genome-wide Tandem Repeat Analysis PR Newswire Analysis Method Supports Research on the Genetic Causes of Common Diseases MENLO PARK, Calif. , Sept. 27, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB),...
PacBio to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference PR Newswire MENLO PARK, Calif. , Sept. 7, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced...
Recent volatility mirror renewed meme-trade bonanza, likely to subdue in coming days, instead of a reflection of a change in the company's market position. Several factors distorted the YoY revenue comparison this quarter, contributing to the inflated top-line growth, including the Bi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: motorolka / Shutterstock.com Various biotech stocks are in focus today, but Pacific Biosciences (NASDAQ: PACB ) is one of the more notable names investors are watching right now. At the time of this w...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cathie Wood’s exchange-traded funds (ETFs) received a breath of fresh air this week. The ARK Innovation ETF (NYSEMKT: ARKK ) ended the period up over 12%. Wood did admit that she believes the U.S. is current...
PacBio to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit PR Newswire MENLO PARK, Calif. , Aug. 5, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will be participating in the upcoming UBS Genomics 2.0 and MedTech Inn...
Image source: The Motley Fool. Pacific Biosciences of California (NASDAQ: PACB) Q2 2022 Earnings Call Aug 03, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Pacific Biosciences of California (PACB) Q2 2022 Earnings...
Pacific Biosciences of California, Inc. (PACB) Q2 2022 Earnings Conference Call August 03, 2022 5:00 PM ET Company Participants Todd Friedman – Director of Investor Relations Christian Henry – President and Chief Executive Officer Susan Kim –...
Pacific Biosciences of California press release ( NASDAQ: PACB ): Q2 Non-GAAP EPS of -$0.34 in-line. Revenue of $35.5M (+16.0% Y/Y) beats by $0.34M . For further details see: Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line, revenue of $35.5M ...
PacBio Announces Second Quarter 2022 Financial Results PR Newswire MENLO PARK, Calif. , Aug. 3, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2022 . Second quarter results...
News, Short Squeeze, Breakout and More Instantly...
Pacific Biosciences of California Inc. Company Name:
PACB Stock Symbol:
NASDAQ Market:
Pacific Biosciences of California Inc. Website:
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, se...
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...